Misa Takegami
Overview
Explore the profile of Misa Takegami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
1605
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Obayashi Y, Miyake M, Takegami M, Amano M, Kitai T, Fujita T, et al.
Circ Rep
. 2024 Nov;
6(11):521-528.
PMID: 39525294
Background: Data on the impact of valve position on clinical outcomes in patients with atrial fibrillation (AF) and bioprosthetic valves (BPVs) are limited. Methods And Results: The BPV-AF Registry was...
2.
Shimamoto K, Dagradi F, Ohno S, Spazzolini C, Crotti L, Giovenzana F, et al.
JACC Clin Electrophysiol
. 2024 Oct;
10(12):2584-2596.
PMID: 39387742
Background: Approximately 15% to 20% of patients clinically diagnosed with long QT syndrome (LQTS) are genotype-negative (GEN-). Whether they have a different arrhythmic risk or should be managed differently remains...
3.
Onuma S, Takahashi J, Shiroto T, Godo S, Hao K, Honda S, et al.
Circ J
. 2024 Oct;
89(3):382-390.
PMID: 39384369
Background: Few studies have investigated the clinical characteristics and in-hospital outcomes of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) using real-world databases in the coronary intervention era. Methods...
4.
Odajima S, Fujimoto W, Takegami M, Nishimura K, Iwasaki M, Okuda M, et al.
J Am Heart Assoc
. 2024 Sep;
13(19):e034793.
PMID: 39344672
Background: Stage B heart failure (HF) refers to structural heart disease without signs or symptoms of HF, so that early intervention may delay or prevent the onset of overt HF....
5.
Inoue K, Nakai M, Yamane T, Kusano K, Takatsuki S, Satomi K, et al.
Eur Heart J Qual Care Clin Outcomes
. 2024 Sep;
PMID: 39243122
Background And Aims: This study evaluated the safety and efficacy of catheter ablation in treating atrial fibrillation (AF) among the elderly population. Methods: A total of 170 017 AF ablation...
6.
Izumi C, Miyake M, Fujita T, Koyama T, Tanaka H, Ando K, et al.
Circ J
. 2024 Aug;
88(9):1598-1602.
PMID: 39183040
No abstract available.
7.
Sano M, Takegami M, Amano M, Tanaka H, Ando K, Kitai T, et al.
Circ Rep
. 2024 Aug;
6(8):341-348.
PMID: 39132334
Background: There are few studies evaluating the prognostic prediction method in atrial fibrillation (AF) patients after bioprosthetic valve (BPV) replacement. The R-CHADS-VASc score is increasingly used for the prediction of...
8.
Amano M, Takegami M, Miyake M, Kitai T, Fujita T, Koyama T, et al.
Int J Cardiol
. 2024 Jul;
413():132375.
PMID: 39025133
Background: Current guidelines recommend direct oral anticoagulants (DOACs) and warfarin for patients with atrial fibrillation (AF) who have a bioprosthetic valve (BPV). However, the data related to elderly patients (aged...
9.
Takahama H, Kitai T, Nakagawa S, Takegami M, Hamatani Y, Nakamoto K, et al.
Circ Rep
. 2024 Jul;
6(7):276-280.
PMID: 38989104
Preplanning of care is necessary for patients with endstage heart failure (HF), but advance care planning (ACP) before the loss of a patient's comprehensive capacity is not yet routine for...
10.
Honda S, Lee S, Cho K, Takegami M, Nishihira K, Kojima S, et al.
Int J Cardiol
. 2024 Jun;
410:132197.
PMID: 38823533
Background: The comparative efficacy and safety of adjusted- and standard-dose prasugrel in East Asian patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) remain unclear. This study aimed...